Vaginal Cancer Causes and Risk Factors

Vaginal cancer is a rare gynecological malignancy that forms within the vaginal canal, the muscular, epithelial-lined pathway connecting the cervix to the external vulva. Because of its structural location, cellular abnormalities in this area are deeply intertwined with a person's broader reproductive and viral health history. Understanding how these cell changes initiate and identifying your specific risk characteristics are vital steps in ensuring early clinical detection and expanding your proactive care options.

What Causes Vaginal Cancer?

Vaginal cancer begins when the genetic blueprint, or DNA, of the cells lining the vaginal wall becomes severely damaged. While the precise biological trigger behind this genetic damage is not yet fully understood, clinical research has established a definitive link to high-risk strains of the Human Papillomavirus (HPV), and in the vast majority of cases, it is a persistent, chronic HPV infection that drives this cellular disruption.

When the virus becomes chronic, it integrates its own genetic material into the host cells, producing specific viral proteins that deactivate the body's natural tumor-suppressor pathways. Without these cellular guardrails, healthy epithelial cells undergo a multi-stage transformation. They begin as precancerous lesions, a state known as vaginal intraepithelial neoplasia (VaIN).

If the immune system or medical interventions do not clear these abnormal cells, they continue to mutate and multiply uncontrollably. Over time, they form a localized mass or tumor that can eventually penetrate deeper into the surrounding muscular walls of the vagina, the lymphatic channels, or distant anatomical structures.

Vaginal Cancer Risk Factors

Having a risk factor does not mean you will definitely develop vaginal cancer. Instead, understanding these variables simply helps you stay proactive and allows your medical team to build a personalized screening plan. Doctors generally divide these risks into two categories: non-modifiable risk factors (inherent biological traits and medical history you cannot change) and modifiable risk factors (behaviors and lifestyle choices you can control).

Non-Modifiable Risk Factors

The majority of documented risk factors for vaginal cancer are entirely unchangeable, stemming from natural aging, historical medical exposures, genetics, or underlying viral interactions. These include:

• Advanced age: The statistical risk of developing this malignancy increases with age. The average age at the time of a vaginal cancer diagnosis is 60, and it is rarely found in younger individuals.
• Exposure to diethylstilbestrol (DES) in utero: Women whose mothers were prescribed the synthetic estrogen drug DES during pregnancy (routinely administered in the U.S. between 1940 and 1971 to prevent miscarriage) face an elevated risk of developing a rare subtype known as clear cell adenocarcinoma.
• Vaginal adenosis: Most frequently identified in individuals exposed to DES in utero, this benign condition occurs when glandular cells form along the epithelial lining of the vaginal walls where they do not normally belong. Left unmonitored, these cellular clusters can gradually transition into cancer.
• Cervical cancer and precancer: A medical history involving cervical dysplasia or cervical cancer significantly elevates your vulnerability to vaginal squamous cell carcinoma. This is primarily because both tissues share an anatomical pathway and a common vulnerability to viral mutations caused by HPV.
• Immune system health: Women living with HIV or active AIDS experience a higher statistical risk of developing vaginal cancer. A weakened immune system struggles to clear out abnormal cell growths, making it much harder for the body to fight off persistent, cancer-driving HPV infections.
• Chronic vaginal irritation: When stretched pelvic ligaments cause the uterus to sag into the vaginal canal (uterine prolapse), a rigid support device called a pessary is often worn to hold it in place. Long-term friction and physical irritation from a pessary against the vaginal walls can slightly increase the risk of vaginal squamous cell carcinoma.

Modifiable Risk Factors

Unlike many common cancers, vaginal cancer has a very limited connection to everyday lifestyle choices. Standard health habits, such as diet, exercise, or weight management, do not appear to influence your baseline risk for developing these tumors.

For this reason, only a few definitive lifestyle changes can alter your risk profile. While the overwhelming medical consensus is that general behavioral factors do not play a primary role, two specific habits have been directly linked to an increased incidence of vaginal squamous cell carcinoma:

• Tobacco use: Smoking commercial tobacco products introduces potent carcinogens into the bloodstream that directly accelerate cellular damage within epithelial tissues. This doubles the statistical risk of developing vaginal cancer and makes it significantly harder for your immune system to clear an underlying HPV infection.
• Excessive alcohol consumption: Regular, heavy alcohol intake acts as a systemic metabolic stressor that can impair immune surveillance, leaving reproductive tissues more vulnerable to persistent viral mutations.

Because you cannot prevent these tumors entirely through lifestyle modifications, adhering to routine pelvic examinations, receiving the HPV vaccine, and promptly reporting any localized swelling, unusual bleeding, or structural changes to a physician are your most effective proactive habits.

Can Vaginal Cancer be Prevented?

While there is no definitive way to completely prevent vaginal cancer, especially when risks are tied to unchangeable factors like aging or historical medical exposures, you can drastically lower your baseline risk. Proactive medical care and targeted lifestyle changes work together to stop abnormal cellular updates before they can turn into invasive tumors.

The most effective prevention strategies include:

• Prioritizing regular pelvic exams and Pap tests: Routine screenings are your strongest line of defense. While a Pap test is primarily designed to look for cervical changes, it frequently captures abnormal cells in the upper vaginal wall as well. This allows gynecological specialists to detect and treat precancerous lesions (VaIN) years before they have a chance to progress.
• Receiving the HPV vaccine: Because persistent Human Papillomavirus infections are the primary driver behind most vaginal squamous cell cancers, the HPV vaccine is a powerful preventative tool. Guarding against these high-risk viral strains essentially cuts off the main biological catalyst for the disease.
• Quitting tobacco use: If you smoke, quitting is one of the most impactful choices you can make for your reproductive health. Eliminating commercial tobacco stops the continuous flow of tissue-damaging carcinogens into your bloodstream and immediately restores your immune system's natural capacity to clear out localized viral infections.

Rated High Performing in Gynecological Cancer Surgery

Recognized in U.S. News & World Report's Best Hospitals for significantly better performance in surgeries for ovarian and uterine cancer than the national average.

Schedule an Appointment

Benefit from World-Class Care at Moffitt Cancer Center

Moffitt offers a full slate of the latest techniques for detecting vaginal cancer in women who are at risk but do not have symptoms. In general, we recommend an annual pelvic exam for all women, as well as HPV testing for women 30 and older. The multispecialty team in our gynecological clinic helps many women achieve the best possible outcome and quality of life by detecting and addressing vaginal cancer early, when there are generally more treatment options available, including promising clinical trials.

Moffitt is also home to a full-time team of more than 800 researchers, all of whom share a commitment to broadening our understanding of how cancer develops and spreads—and most importantly, how it can be prevented and cured. Our research team leads groundbreaking discoveries on a regular basis, and then fast-tracks those discoveries into new diagnostic tools and treatments. In recognition of our notable contributions to cancer research, the National Cancer Institute has designated Moffitt a Comprehensive Cancer Center. 

If you would like to learn more about vaginal cancer causes and risk factors, a specialist in our gynecological clinic can provide detailed information and create an individualized risk profile for you. To request an appointment, call 1-888-663-3488 or submit a new patient registration form online. No referral is necessary.